EUR 72,01
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 74,36
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 73,86
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 75,79
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 73,20
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 81,02
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 9,49
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Hervorragend. Zustand: Hervorragend | Seiten: 304 | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2010
ISBN 10: 3838340698 ISBN 13: 9783838340692
Da: preigu, Osnabrück, Germania
EUR 66,40
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Biological activities of certain Indian medicinal plants | Extracts with therapeutic potential | Farrukh Aqil (u. a.) | Taschenbuch | 256 S. | Englisch | 2010 | LAP LAMBERT Academic Publishing | EAN 9783838340692 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Lingua: Inglese
Editore: LAP Lambert Academic Publishing, 2010
ISBN 10: 3838340698 ISBN 13: 9783838340692
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 132,25
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: Libro Co. Italia Srl, San Casciano Val di Pesa, FI, Italia
EUR 149,15
Quantità: 1 disponibili
Aggiungi al carrelloRilegato in Tela. Condizione: fine. English Text.Oxford, 2008; clothbound, pp. 304, cm 18x24. Libro.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 217,25
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 225,23
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 225,23
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 239,42
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 241,55
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 196,70
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Very Good.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 235,11
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 235,10
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 254,09
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 184,85
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Combating Fungal Infections | Problems and Remedy | Iqbal Ahmad (u. a.) | Taschenbuch | xx | Englisch | 2014 | Springer | EAN 9783642446726 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 262,87
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 248,54
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 155,66
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Sehr gut. Zustand: Sehr gut | Seiten: 560 | Sprache: Englisch | Produktart: Bücher | Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef?cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi?ed and validated.
EUR 212,80
Quantità: 1 disponibili
Aggiungi al carrelloGebunden. Condizione: New. .Primariliy, this book is dedicated, but also highly recommended, to students, teachers and researchers enganged in universities, R&D insitutions, pharmaceutical or herbal industry, as well as health organizations. Advances in Food Sciences, 07/2007| Die.
EUR 242,00
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware -This timely and original handbook paves the way to success in plant-based drug development, systematically addressing the issues facing a pharmaceutical scientist who wants to turn a plant compound into a safe and effective drug. Plant pharmacologists from around the world demonstrate the potentials and pitfalls involved, with many of the studies and experiments reported here published for the first time. The result is a valuable source of information unavailable elsewhere. 384 pp. Englisch.
EUR 242,00
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware -This timely and original handbook paves the way to success in plant-based drug development, systematically addressing the issues facing a pharmaceutical scientist who wants to turn a plant compound into a safe and effective drug. Plant pharmacologists from around the world demonstrate the potentials and pitfalls involved, with many of the studies and experiments reported here published for the first time. The result is a valuable source of information unavailable elsewhere. 384 pp. Englisch.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 261,34
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 202,95
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Modern Phytomedicine | Turning Medicinal Plants into Drugs | Iqbal Ahmad (u. a.) | Buch | XX | Englisch | 2006 | Wiley-VCH | EAN 9783527315307 | Verantwortliche Person für die EU: Wiley-VCH GmbH, Boschstr. 12, 69469 Weinheim, product-safety[at]wiley[dot]com | Anbieter: preigu.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 2014
ISBN 10: 3642446728 ISBN 13: 9783642446726
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 213,99
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi ed and validated.